Fuad El-Hibri and the Heifetz International Music Institute
The Heifetz International Music Institute was established by Daniel Heifetz and is based in Ellicott City, Maryland. The institute also holds a six-week long summer festival program to train young musicians, held at Brewster Academy in New Hampshire.
The founder, violinist Daniel Heifetz, has played with many world-renowned orchestras and has taught master classes as well as [...]
In: Chief executive officer, Emergent BioSolutions, Music · Tagged with: Daniel Heifetz, Heifetz International Music Institute, Jascha Brodsky, Maryland, United States
Maryland Governor Martin O’Malley Leads Ribbon Cutting Ceremony at Emergent’s Baltimore Manufacturing Facility
ROCKVILLE, MD, July 16, 2010 – Emergent BioSolutions Inc. (NYSE:EBS) today held a ribbon cutting ceremony, led by Governor Martin O’Malley and Fuad El-Hibri, Emergent’s chairman and chief executive officer, to mark the formal opening of Emergent Manufacturing Operations [...]
In: Biothrax, Chief executive officer, Emergent BioSolutions, Food and Drug Administration, Fuad El-Hibri, Health Care, Management, Research and development, U.S. Food and Drug Administration · Tagged with: Chief executive officer, Emergent BioSolutions, Employment, Fuad El-Hibri, Martin O'Malley, Maryland, United States
Emergent BioSolutions Chairman and CEO Fuad El-Hibri Recognized as Outstanding International Business Leader
ROCKVILLE, Md., Mar 11, 2010 (BUSINESS WIRE) — Emergent BioSolutions Inc. (EBS 15.96, -0.03, -0.19%) announced today that Fuad El-Hibri, its chairman and chief executive officer, has been named by the World Trade Center Institute (WTCI) as one of Maryland’s outstanding international business leaders. Celebrating the spirit of global ambition and excellence in international leadership, [...]
In: Business, Chief executive officer, Emergent BioSolutions, Food and Drug Administration, Management, U.S. Food and Drug Administration, biotechnology · Tagged with: Baltimore, Chief executive officer, Emergent BioSolutions, Fuad El-Hibri, Maryland
Emergent BioSolutions Enhances Manufacturing Infrastructure with Strategic Acquisition in Baltimore
Emergent acquires manufacturing facility from MdBio and land from City of Baltimore for $8.2 million
ROCKVILLE, MD, November 13, 2009 – Emergent BioSolutions Inc. (NYSE:EBS) announced today that it has completed the acquisition of a 55,000 square foot manufacturing facility from MdBio Foundation and the land on which the facility stands from the City of Baltimore [...]
In: Fuad El-Hibri · Tagged with: Chief executive officer, Emergent BioSolutions, Food and Drug Administration, Fuad El-Hibri, Martin O'Malley, Maryland, State of Maryland, United States
Emergent Biosolutions Expands Presence In Germany
Acquires Vivacs GmbH Along with Rights to Modified Vaccinia Virus Ankara (MVA) Strain and Monoclonal Vector Technology Platform (MVAtorTM)
GAITHERSBURG, MD., August 03, 2006—Emergent BioSolutions Inc., a privately held biopharmaceutical company, today announced it has completed the acquisition of Vivacs GmbH, a privately held biotechnology company based in Munich, Germany. Financial details of the transaction were [...]
In: Emergent BioSolutions, Fuad El-Hibri, Vivacs GmbH · Tagged with: Biotechnology and Pharmaceuticals, Business, Chief executive officer, Emergent BioSolutions, Germany, Infectious disease, Maryland, Munich